List of SBIR/STTR awards granted to Modulation Therapeutics
Modulation TherapeuticsA SBIR Phase II contract was awarded to Modulation Therapeutics in September, 2018 for $1,929,583.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A STTR Phase II contract was awarded to Modulation Therapeutics in September, 2018 for $2,000,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase I contract was awarded to Modulation Therapeutics in September, 2018 for $248,155.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase I contract was awarded to Modulation Therapeutics in September, 2022 for $399,986.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A STTR Phase I contract was awarded to Modulation Therapeutics in February, 2019 for $258,700.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A STTR Phase I contract was awarded to Modulation Therapeutics in August, 2017 for $283,986.0 USD from the U.S. Department of Health & Human Services.
A STTR Phase I contract was awarded to Modulation Therapeutics in March, 2016 for $279,000.0 USD from the U.S. Department of Health & Human Services.
A STTR Phase I contract was awarded to Modulation Therapeutics in July, 2015 for $244,801.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Modulation Therapeutics in September, 2017 for $242,056.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Modulation Therapeutics for $299,336.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Modulation Therapeutics for $218,817.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Modulation Therapeutics for $156,202.0 USD from the U.S. Department of Health & Human Services.
A STTR Phase I contract was awarded to Modulation Therapeutics for $225,000.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase II contract was awarded to Modulation Therapeutics for $1,999,987.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Modulation Therapeutics for $288,301.0 USD from the U.S. Department of Health & Human Services.
